Skip to main content
SpringerLink
Log in

The correlation of the lifestyle and medical conditions with the vaginal infections and production of 2-phenylethanol

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

The objective of this study was determination of causative factors of the genital infections and their correlation with various predictor variables. Secondary objectives included: (1) determination of the presence and the type of low molecular weight metabolites in the samples of vaginal secretion formed in vivo, (2) determination of the concentration of 2-phenylethanol formed in vitro for each Candida species, (3) determination of the relationship between fungal/bacterial/viral infections with the metabolites formed in vivo using multivariate analysis.

Methods

One hundred and ninety-seven women in the age range from 18 to 65 years were included in the study. After the completion of questionnaire, all the patients were subjected to Pap test, cervical swabs for the presence of aerobic bacteria, yeasts, Ureaplasma urealyticum, Chlamydia trachomatis, Mycoplasma, and hrHPV DNA. The presence and the concentration of low-molecular weight metabolites in vitro and in vivo were determined by gas chromatography-mass spectrometry (GC–MS) method. Multivariate analysis methods were used for statistical evaluation.

Results

The most important risk factors of fungal/bacterial/viral infections were determined. The presence of 2-phenylethanol in vivo was confirmed in 14 of 74 tested samples and connected with the Candida species. The presence of symptoms, hrHPV DNA and Ureaplasma urealyticum are the predictor variables with the highest influence on the formation of the metabolite in vivo. The results in vitro confirmed that various Candida species produced 2-phenylethanol with the concentrations ranging from 0.6 to 4.64 μg/mL.

Conclusion

The medical exposure to irradiation, marital status, and number of partners as well as stress factors (miscarriages, chronic, viral, or tumor illnesses) had the highest influence on the development of the bacterial/fungal/viral infections. The formation of 2-phenylethanol, both in vivo and in vitro, was confirmed and connected with Candida species. Besides, according to statistical tests, it seems that presence of symptoms, hrHPV DNA, and Ureaplasma urealyticum had also significant role on the formation of 2-phenylethanol in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Monif GRG, Welkos SL, Baer H (1982) Impact of diverging anaerobic technology on cul-de-sac isolates from patients with endometritis/salpingitis/peritonitis. Am J Obstet Gynecol 124:896–897

    Google Scholar 

  2. Roy S, Sharma M, Ayyagari A, Malhotra S (1994) A quantitative study of bacterial vaginosis. Indian J Med Res 100:172–176

    PubMed  CAS  Google Scholar 

  3. Monif GRG (1999) Semiquantitative bacterial observations with group B streptococcal vulvovaginitis. Infect Dis Obstet Gynecol 7:227–229

    PubMed  CAS  Google Scholar 

  4. Larsen B, Monif GRG (2001) Understanding the bacterial flora of the female genital tract. CID 32:69–77

    Article  Google Scholar 

  5. Taylor-Robinson D, Bebear C (1997) Antibiotic susceptibility of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 40:622–630

    Article  PubMed  CAS  Google Scholar 

  6. Waites KB, Taylor-Robinson D (1999) Mycoplasma and ureaplasma. In: Murray PR, Barron EJ, Pfaller MA, Tenover F, Yolken RH (eds) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington DC, pp 782–794

    Google Scholar 

  7. Klenic S (2001) Micoplasmas. In: Kalenic S, Mlinaric-Missoni E (eds) Medical bacteriology and mycology (in Croatian). Merkur A.B.D, Zagreb, pp 315–320

    Google Scholar 

  8. Elgui de Oliveira D (2007) DNA viruses in human cancer: an integrated overview of fundamental mechanisms of viral carcinogenesis. Cancer Lett 247:182–196

    Article  PubMed  CAS  Google Scholar 

  9. Zur Hausen H, De Villiers E (1994) Human papillomaviruses. Ann Rev Microbiol 48:427–447

    Article  CAS  Google Scholar 

  10. Rahm VA, Odlind V, Pettersson R (1991) Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infections: a prospective study. Genitourin Med 67:317–321

    PubMed  CAS  Google Scholar 

  11. Kosalec I, Pepeljnjak S, Delaforge M, Puel O, Galtier P (2004) Possible toxicity of clinical isolates of C. albicans. In: Balenovic M, Wittner V (eds) Proceedings of the third Croatian Microbiological Congress with international participation, Porec, Croatia, 4–7 October 2004. Croatian Microbiological Society, Zagreb, p 115

  12. Kosalec I, Pepeljnjak S, Antolović R, Jelić D, Galtier P, Puel O (2005) Cytotoxicity screening of low-molecular-weight metabolites of Candida spp. Acta Microbiologica et Immunologica Hungarica (CEFORM), Akademiai Kiado, Budapest, p 80

  13. Munro C (2010) Candida albicans cell wall mediated virulence. In: Ashbee HR, Bignell ME (eds) The yeast handbook, pathogenic yeasts. Springer, Heidelberg, p 367

    Google Scholar 

  14. Moran PG, McManus B, Coleman CD, Sullivan JD (2010) Molecular epidemiology of Candida species. In: Ashbee HR, Bignell ME (eds) (2010) The yeast handbook, pathogenic yeasts. Springer, Heidelberg, p 367

  15. Gujjar P, Finucane M, Larsen B (1997) The effect of estradiol on Candida albicans growth. Ann Clin Lab Sci 27:151–156

    PubMed  CAS  Google Scholar 

  16. Glover DD, Larsen B (1998) Longitudinal investigation of Candida vaginitis in pregnancy: role of superimposed antibiotic use. Obstet Gynecol 91:115–118

    Article  PubMed  CAS  Google Scholar 

  17. Kosalec I, Puel O, Delaforge M, Kopjar N, Antolovic R, Jelic D, Matica B, Galtier P, Pepeljnjak S (2008) Isolation and cytotoxicity of low-molecular-weight metabolites of Candida albicans. Front Biosci 13:6893–6894

    Article  PubMed  CAS  Google Scholar 

  18. Kosalec I, Safranic A, Pepeljnjak S, Bacun-Druzina V, Ramic S, Kopjar N (2008) Genotoxicity of tryptophol in a battery of short-term assays on human white blood cells in vitro. Basic Clin Pharmacol Toxicol 102:443–452

    Article  PubMed  CAS  Google Scholar 

  19. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M (1999) Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res 23:1409–1415

    Article  PubMed  CAS  Google Scholar 

  20. Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN (1998) The microflora associated with human oral carcinomas. Oral Oncol 34:304–308

    PubMed  CAS  Google Scholar 

  21. Obe G, Jonas R, Schmidt S (1986) Metabolism of ethanol in vitro produces a compound which induces sister-chromatid exchanges in human peripheral lymphocytes in vitro: acetaldehyde not ethanol is mutagenic. Mutat Res 174:47–51

    Article  PubMed  CAS  Google Scholar 

  22. World Health Organization (1985) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 36. International Agency for Research on Cancer, Lyon, France, pp 101–132

  23. World Health Organization (1988) IARC monographs on the evaluation of carcinogenic risk to humans, vol 44. International Agency for Research on Cancer, Lyon, France, pp 115

  24. Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M (1997) High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenic implications. Carcinogenesis 18:1739–1743

    Article  PubMed  CAS  Google Scholar 

  25. Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M (2002) Removal of acetaldehyde from saliva by a slow-release buccal tablet of l-cysteine. Int J Cancer 97:361–364

    Article  PubMed  CAS  Google Scholar 

  26. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fujinaga K (1991) Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72:1039–1044

    Article  PubMed  CAS  Google Scholar 

  27. O’Connell E, Brennan W, Cormican M, Glacken M, O’Donovan D, Vellinga A, Cahill N, Lysaght F, O’Donnell J (2009) Chlamydia trachomatis infection and sexual behaviour among female students attending higher education in the Republic of Ireland. BMC Pub Health 9:397–398

    Article  Google Scholar 

  28. Colliers A, Verster A, Van Puyenbroeck K, Stalpaert M, Van Royen P, Verhoeven V (2009) Screening Belgian university students for Chlamydia trachomatis infection: a feasibility study. Int J Adolesc Med Health 21(3):343–346

    Article  PubMed  Google Scholar 

  29. Gram IT, Macaluso M, Stalsberg H (1998) Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening. Acta Obstet Gynecol Scand 77(2):228–232

    Article  PubMed  CAS  Google Scholar 

  30. Ho GYF, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL (1998) HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78:281–285

    Article  PubMed  CAS  Google Scholar 

  31. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, Neal K, Waugh N (2007) Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer 97:133–139

    Article  PubMed  CAS  Google Scholar 

  32. Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G (2008) Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol 42:211–214

    Article  PubMed  Google Scholar 

  33. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjańczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJF, Meijer CJLM, Zatonski W, Franceschi S (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44:557–564

    Article  PubMed  CAS  Google Scholar 

  34. Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L, Chauhan SC (2007) There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. Gynecol Oncol 107:236–241

    Article  PubMed  Google Scholar 

  35. Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M (2011) A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infect Agents Cancer 6:12–19

    Article  PubMed  Google Scholar 

  36. Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J, Bass DC, Sweet RL, Rice P (2002) Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100:765–772

    Article  PubMed  Google Scholar 

  37. Russo JF, Coppola K, Furness G (1981) Mycoplasma hominis, Ureaplasma urealyticum, and Corynebacterium genitalium recovered from the lower genital tracts of adolescent women. Int J Gynecol Obstet 19:461–466

    Article  CAS  Google Scholar 

  38. van der Schee C, Sluiters HJF, van der Meijden WI, van Beek P, Peerbooms P, Verbrugh H, van Belkum A (2001) Host and pathogen interaction during vaginal infection by Trichomonas vaginalis and Mycoplasma hominis or Ureaplasma urealyticum. J Microbiol Meth 45:61–67

    Article  Google Scholar 

  39. Pordeli HA (2008) Prevalence and detection of Ureaplasma urealyticum and Mycoplasma hominis in endocervical specimens from women with genitourinary tract diseases in Iran. Int J Infect Dis 12(Suppl 1):e179

    Article  Google Scholar 

  40. Young H, Tuach S, Bain SSR (1981) Incidence of Ureaplasma urealyticum infection in women attending a clinic for sexually transmitted disease. J Infect 3:258–265

    Article  PubMed  CAS  Google Scholar 

  41. Sobel JD (2007) Vulvovaginal candidosis. Lancet 369:1961–1971

    Article  PubMed  Google Scholar 

  42. Guijon F, Paraskevas M, Rand F, Heywood E, Brunham R, McNicol P (1992) Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int J Gynecol Obstet 37:185–191

    Article  CAS  Google Scholar 

  43. Takac I (1998) The frequency of bacterial and yeast infection in women with different grades of cervical intraepithelial neoplasia (CIN). Eur J Obstet Gynecol Rep Biol 80:231–234

    Article  CAS  Google Scholar 

  44. Gregus P, Vlcková H, Buchta V, Kestranek J, Krivcíková L, Nováková L (2010) Ultra high performance liquid chromatography tandem mass spectrometry analysis of quorum-sensing molecules of Candida albicans. J Pharm Biomed Anal 53(3):674–681

    Article  PubMed  CAS  Google Scholar 

  45. Chen H, Fink GR (2006) Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev 20:1150–1161

    Article  PubMed  CAS  Google Scholar 

  46. Alem MA, Oteef MD, Flowers TH, Douglas LJ (2006) Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 5:1770–1779

    Article  PubMed  CAS  Google Scholar 

  47. Chen HM, Feng FQ, Clardy J, Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA 101:5048–5052

    Article  PubMed  CAS  Google Scholar 

  48. Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R (2007) Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot Cell 6(12):2429–2436

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Findri-Guštek Ltd, Ninska 5A, Sesvete, Zagreb, Croatia

    Štefica Findri-Guštek

  2. Center for Forensic Testing, Research and Expertise, “Ivan Vucetic”, Interior Ministry, RH, Ilica, 335, Zagreb, Croatia

    Maja Jelena Petek, Hrvoje Sarajlija & Gordan Mršić

  3. Institute of Public Health, “dr Andrija Štampar”, Mirogojska 16, Zagreb, Croatia

    Ana Mlinarić Džepina

  4. Advanced Energy Ltd, V. Prekrata 43, Zagreb, Croatia

    Višnja Oreščanin

Authors
  1. Štefica Findri-Guštek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maja Jelena Petek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hrvoje Sarajlija
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gordan Mršić
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Mlinarić Džepina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Višnja Oreščanin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Višnja Oreščanin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Findri-Guštek, Š., Petek, M.J., Sarajlija, H. et al. The correlation of the lifestyle and medical conditions with the vaginal infections and production of 2-phenylethanol. Arch Gynecol Obstet 286, 671–682 (2012). https://doi.org/10.1007/s00404-012-2346-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2346-y

Keywords

Search

Navigation